Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 2Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 12Esophageal Squamous Cell Carcinoma 7Carcinoma, Non-Small-Cell Lung 6Rectal Neoplasms 5Uterine Cervical Neoplasms 4Pancreatic Neoplasms 4Head and Neck Neoplasms 3Glioblastoma 3Brain Neoplasms 3Stomach Neoplasms 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Hyperthermia 2Anus Neoplasms 2Adenocarcinoma 2Unresectable Stage III NSCLC 1Thymic epithelial tumor 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Recurrence 1Rare Diseases 1Prostatic Neoplasms 1Pleural Effusion, Malignant 1Ovarian Neoplasms 1Neoplasm Metastasis 1Mucositis 1Metastasising Cancer of Unknown Primary 1Medulloblastoma 1Lymphoma, B-Cell, Marginal Zone 1Locally Advanced Rectal Cancer 1

Interventions

Gemcitabine 12Oxaliplatin 8Capecitabine 6apatinib 5tislelizumab 4lenvatinib 4Surgical Procedures, Operative 4Radiofrequency Ablation 4Neoadjuvant Therapy 4Fluorouracil 4Cisplatin 4toripalimab 3sintilimab 3Radiotherapy 3Leucovorin 3Irinotecan 3regorafenib 2pembrolizumab 2camrelizumab 2Stents 2Photochemotherapy 2Immunotherapy 2Hepatectomy 2Folfox protocol 2Everolimus 2Drug Therapy 2Cholangiopancreatography, Endoscopic Retrograde 2Blood Specimen Collection 21-phenyl-3,3-dimethyltriazene 2surufatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Cholangiocarcinoma × Radiation × Clear all
NCT02773485 2022-10-21

Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma

Tata Memorial Hospital

Phase 3 Unknown
155 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡